Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Atkins

Showing results (51-60 of 357) with videos related to

Pageof 36
Sort By:
Lancet (London, England)|May 9, 2000
Long-term outcome of invasive breast cancerC D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancerCarl D Atkins
The New England Journal of Medicine|October 27, 1994
Preventive health servicesC D Atkins
JAMA|February 22, 1995
Estrogen replacement therapy in breast cancer survivorsC D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Effect of flutamide withdrawal on response assessment of estramustine and etoposide for prostate cancerC D Atkins
Ontario Dentist|December 1, 1974
Dentistry for the handicappedG D Atkins
The New England Journal of Medicine|August 11, 1994
Interferon alfa-2a for chronic myeloid leukemiaC D Atkins
Journal of the National Cancer Institute|February 20, 2003
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinomaCarl D Atkins
Annals of Internal Medicine|February 21, 1998
Locating and appraising systematic reviewsC D Atkins
Journal of the National Cancer Institute|February 5, 1998
Re: oncologists judge themselves the best judges of cancer treatmentsC D Atkins
Pageof 36

Showing results (51-60 of 357) with videos related to

Sort By:
Pageof 36
Lancet (London, England)|May 9, 2000
Long-term outcome of invasive breast cancerC D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancerCarl D Atkins
The New England Journal of Medicine|October 27, 1994
Preventive health servicesC D Atkins
JAMA|February 22, 1995
Estrogen replacement therapy in breast cancer survivorsC D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Effect of flutamide withdrawal on response assessment of estramustine and etoposide for prostate cancerC D Atkins
Ontario Dentist|December 1, 1974
Dentistry for the handicappedG D Atkins
The New England Journal of Medicine|August 11, 1994
Interferon alfa-2a for chronic myeloid leukemiaC D Atkins
Journal of the National Cancer Institute|February 20, 2003
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinomaCarl D Atkins
Annals of Internal Medicine|February 21, 1998
Locating and appraising systematic reviewsC D Atkins
Journal of the National Cancer Institute|February 5, 1998
Re: oncologists judge themselves the best judges of cancer treatmentsC D Atkins
Pageof 36